Profile
Javad Shahidi worked as Vice President-Global Research & Development at Daiichi Sankyo, Inc. from 2019 to 2022.
He also worked as Chief Medical Officer at Centessa Pharmaceuticals Plc in 2022.
Prior to his professional experience, he earned a graduate degree from McGill University and a doctorate degree from Shahid Beheshti University of Medical Sciences.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-10-02 | 158,932 ( 0.18% ) | 1 M $ | 2024-04-29 |
Former positions of Javad Shahidi
Companies | Position | End |
---|---|---|
CENTESSA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 2022-10-13 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Chief Tech/Sci/R&D Officer | 2022-02-28 |
Training of Javad Shahidi
Shahid Beheshti University of Medical Sciences | Doctorate Degree |
McGill University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CENTESSA PHARMACEUTICALS PLC | Health Technology |
Private companies | 1 |
---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Stock Market
- Insiders
- Javad Shahidi